209 related articles for article (PubMed ID: 1973547)
1. Atypical neuroleptics in acute schizophrenia: a double-blind comparative study of remoxipride and haloperidol.
den Boer JA; Westenberg HG
Psychopharmacol Bull; 1990; 26(1):99-107. PubMed ID: 1973547
[TBL] [Abstract][Full Text] [Related]
2. Double blind comparative study of remoxipride and haloperidol in acute schizophrenic patients.
Den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
Psychopharmacology (Berl); 1990; 102(1):76-84. PubMed ID: 1975448
[TBL] [Abstract][Full Text] [Related]
3. A double-blind comparative multicentre study of controlled-release remoxipride, immediate-release remoxipride and haloperidol in schizophrenia.
Hebenstreit GF; Laux G; Schubert H; Beckmann H; Amman J; Bunse J; Eikmeier G; Geretsegger C; Kanitz RD; Kanzow WT
Pharmacopsychiatry; 1991 Sep; 24(5):153-8. PubMed ID: 1685572
[TBL] [Abstract][Full Text] [Related]
4. A double-blind comparative study of remoxipride and haloperidol in acute schizophrenia.
den Boer JA; Ravelli DP; Huisman J; Ohrvik J; Verhoeven WM; Westenberg HG
Acta Psychiatr Scand Suppl; 1990; 358():108-10. PubMed ID: 1978468
[TBL] [Abstract][Full Text] [Related]
5. A comparison of an atypical and typical antipsychotic, zotepine versus haloperidol in patients with acute exacerbation of schizophrenia: a parallel-group double-blind trial.
Petit M; Raniwalla J; Tweed J; Leutenegger E; Dollfus S; Kelly F
Psychopharmacol Bull; 1996; 32(1):81-7. PubMed ID: 8927680
[TBL] [Abstract][Full Text] [Related]
6. A double blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
Andersen J; Kørner A; Ostergaard P; Fensbo C; Birket-Smith M; Thiesen S; Hansen NR; Fogh M; Kristensen M; Møller-Nielsen EM
Acta Psychiatr Scand Suppl; 1990; 358():104-7. PubMed ID: 1978467
[TBL] [Abstract][Full Text] [Related]
7. Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride. The Canadian Remoxipride Group.
Awad AG; Lapierre YD; Angus C; Rylander A
J Psychiatry Neurosci; 1997 Jul; 22(4):244-8. PubMed ID: 9262046
[TBL] [Abstract][Full Text] [Related]
8. A double-blind comparative multicentre study of remoxipride and haloperidol in schizophrenia.
Lindström LH; Wieselgren IM; Struwe G; Kristjansson E; Akselson S; Arthur H; Andersen T; Lindgren S; Norman O; Naimell L
Acta Psychiatr Scand Suppl; 1990; 358():130-5. PubMed ID: 1978472
[TBL] [Abstract][Full Text] [Related]
9. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
10. Remoxipride and haloperidol in schizophrenia: a double-blind multicentre study.
Ahlfors UG; Rimön R; Appelberg B; Hagert U; Harma P; Katila H; Mahlanen A; Mehtonen OP; Naukkarinen H; Outakoski J
Acta Psychiatr Scand Suppl; 1990; 358():99-103. PubMed ID: 1978501
[TBL] [Abstract][Full Text] [Related]
11. Amisulpride versus haloperidol in treatment of schizophrenic patients--results of a double-blind study.
Delcker A; Schoon ML; Oczkowski B; Gaertner HJ
Pharmacopsychiatry; 1990 May; 23(3):125-30. PubMed ID: 1973843
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disorders.
Mendlewicz J; de Bleeker E; Cosyns P; Deleu G; Lotstra F; Masson A; Mertens C; Parent M; Peuskens J; Suy E
Acta Psychiatr Scand Suppl; 1990; 358():138-41. PubMed ID: 1978474
[TBL] [Abstract][Full Text] [Related]
13. Remoxipride and haloperidol in the acute phase of schizophrenia: a double-blind comparison.
Deo R; Soni S; Rastogi SC; Levine S; Plant I; Edwards JG; Mitchell M; Chanas A
Acta Psychiatr Scand Suppl; 1990; 358():120-4. PubMed ID: 1978470
[TBL] [Abstract][Full Text] [Related]
14. Clinical profile of remoxipride--a combined analysis of a comparative double-blind multicentre trial programme.
Lewander T; Westerbergh SE; Morrison D
Acta Psychiatr Scand Suppl; 1990; 358():92-8. PubMed ID: 1978500
[TBL] [Abstract][Full Text] [Related]
15. A dose-finding study with remoxipride in the acute treatment of schizophrenic patients.
Lapierre YD; Ancill R; Awad G; Bakish D; Beaudry P; Bloom D; Chandrasena R; Das M; Durand C; Elliott D
J Psychiatry Neurosci; 1992 Oct; 17(4):134-45. PubMed ID: 1450186
[TBL] [Abstract][Full Text] [Related]
16. Acute antipyschotic efficacy and side effects in schizophrenia: association with serotonin transporter promoter genotypes.
Dolzan V; Serretti A; Mandelli L; Koprivsek J; Kastelic M; Plesnicar BK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1562-6. PubMed ID: 18573584
[TBL] [Abstract][Full Text] [Related]
17. Striatal dopaminergic D2 receptor occupancy and clinical efficacy in psychosis exacerbation: a 123I-IBZM study with ziprasidone and haloperidol.
Corripio I; Catafau AM; Perez V; Puigdemont D; Mena E; Aguilar Y; Carrió I; Alvarez E
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jan; 29(1):91-6. PubMed ID: 15610950
[TBL] [Abstract][Full Text] [Related]
18. Amoxapine as an antipsychotic: comparative study versus haloperidol.
Chaudhry IB; Husain N; Khan S; Badshah S; Deakin B; Kapur S
J Clin Psychopharmacol; 2007 Dec; 27(6):575-81. PubMed ID: 18004123
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy and safety comparison of sertindole and haloperidol in the treatment of schizophrenia. The Sertindole Study Group.
Daniel DG; Wozniak P; Mack RJ; McCarthy BG
Psychopharmacol Bull; 1998; 34(1):61-9. PubMed ID: 9564200
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
Buckley PF
Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]